CARE Ratings Limited Announces Q2 FY27 Financial Results and Declares Interim Dividend
CARE Ratings Limited reported Q2 FY27 results with consolidated income at ₹17,956.05 lakh and standalone income at ₹15,040.83 lakh. Consolidated net profit after tax was ₹7,236.70 lakh for the quarter. The company declared an interim dividend of ₹10 per equity share.
The financial results and dividend declaration are material information for investors, impacting share price and investor decisions. However, the impact is considered medium as it reflects routine financial reporting and dividend distribution.
The announcement reports positive financial results for the quarter and half-year, including an increase in income and profit. The declaration of an interim dividend further reinforces a positive sentiment.
CARE Ratings Limited has announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. The company reported a total income from operations of ₹17,956.05 lakh for the consolidated segment and ₹15,040.83 lakh for the standalone segment for the quarter ended September 30, 2026.
For the consolidated results, the net profit after tax for the quarter stood at ₹7,236.70 lakh, and for the half-year ended September 30, 2026, it was ₹10,535.96 lakh. The standalone net profit after tax for the quarter was ₹6,915.88 lakh, and for the half-year, it was ₹10,304.24 lakh.
The Board of Directors, at its meeting held on October 29, 2026, declared an interim dividend of ₹10 per equity share of face value ₹10 each. The company also informed that the detailed financial results, along with the limited review report, are available on the websites of BSE, NSE, and CARE Ratings' own website.
What to do with a filing like this
CARE Ratings Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CARE Ratings Limited. Read the original for the full detail.